<SEC-DOCUMENT>0001213900-24-000296.txt : 20240102
<SEC-HEADER>0001213900-24-000296.hdr.sgml : 20240102
<ACCEPTANCE-DATETIME>20240102164743
ACCESSION NUMBER:		0001213900-24-000296
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231229
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240102
DATE AS OF CHANGE:		20240102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasithea Therapeutics Corp.
		CENTRAL INDEX KEY:			0001841330
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				851591963
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40804
		FILM NUMBER:		24503166

	BUSINESS ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
		BUSINESS PHONE:		8184226172

	MAIL ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea190803-8k_pasithea.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:KTTA="http://pasithea.com/20231229">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_KTTA_pasithea.com_20231229 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20231229_20231229 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001841330 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityCentralIndexKey">0001841330</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ktta-20231229.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-12-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20231229__20231229_z7CT0vaT9Bx5"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 Or 15(D) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90E_edei--DocumentPeriodEndDate_c20231229__20231229_zTepHbDnZzKj"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 29, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20231229__20231229_ziz3JyNyX3wf"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityRegistrantName">Pasithea Therapeutics Corp.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20231229__20231229_zu6Uyejm4rQ7"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20231229__20231229_zzkzwiv72Td"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityFileNumber">001-40804</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20231229__20231229_zObC5R0qkudl"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityTaxIdentificationNumber">85-1591963</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction <br />
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 50%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20231229__20231229_zEPBzxGpKGEe"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressAddressLine1">4400 Route 9 South</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20231229__20231229_zrwMnBAYtgli"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressAddressLine2">Suite 3100</ix:nonNumeric></span></b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20231229__20231229_zFlzKkRE0FZd"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressCityOrTown">Miami Beach</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20231229__20231229_zDIGaO5fWxe4"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span></b></span></p></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20231229__20231229_zxK1w5zYUo2i"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:EntityAddressPostalZipCode">33139</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including area code:
<b>(<span id="xdx_909_edei--CityAreaCode_c20231229__20231229_z5vIHtxGkyxd"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:CityAreaCode">786</ix:nonNumeric></span>) <span id="xdx_908_edei--LocalPhoneNumber_c20231229__20231229_zz6aBX5Xdal4"><ix:nonNumeric contextRef="AsOf2023-12-29" name="dei:LocalPhoneNumber">977-3380</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;(Former name or former address, if changed
since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20231229__20231229_zupqli5C3gwj"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SolicitingMaterial_c20231229__20231229_zu0iSm0tb7A2"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementTenderOffer_c20231229__20231229_zEsZ29ZpBwCf"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20231229__20231229_zhzhGLPsq44"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zVRpUPb9dk8e"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zfOObVlr0huf"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">KTTA</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90D_edei--SecurityExchangeName_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zkmvEcxktDZh"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--Security12bTitle_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zEDckTl07Xib"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Warrants to purchase shares of Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zSgItGOqfDeg"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">KTTAW</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_900_edei--SecurityExchangeName_c20231229__20231229__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zhinggiKCOng"><ix:nonNumeric contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.1pt; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span id="xdx_901_edei--EntityEmergingGrowthCompany_c20231229__20231229_zjkRu7LwOEce"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10.1pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90E_edei--EntityExTransitionPeriod_c20231229__20231229_zX0el6iiOdug"><ix:nonNumeric contextRef="AsOf2023-12-29" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.03. Material Modification to Rights
of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The information contained in
Item 5.03 below is incorporated by reference into this Item 3.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><i>Amended and Restated Certificate
of Incorporation </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed in Item 5.07
below, at the reconvened portion of the 2023 Annual Meeting of Stockholders (the &#8220;Reconvened Meeting&#8221;) of Pasithea Therapeutics
Corp. (the &#8220;Company&#8221;) held on December 29, 2023, the Company&#8217;s stockholders approved an amendment and restatement of
the Company&#8217;s Amended and&#160;Restated&#160;Certificate&#160;of Incorporation (the &#8220;Certificate,&#8221; as amended and restated,
the &#8220;Restated Certificate&#8221;) to include the following changes, which the Company believes represent best practices and improve
the quality of the Company&#8217;s corporate governance practices:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide for processes and procedures for the appointment of additional directors to the Board of Directors of the Company (the &#8220;Board&#8221;) required by the terms of any preferred stock that may be issued by the Company;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remove the ability of stockholders to call special meetings of the stockholders (the Company&#8217;s Amended and Restated Bylaws (the &#8220;Bylaws&#8221;) currently restrict stockholders&#8217; ability to call special meetings, but upon approval of Proposal 4 it will instead be included in the Restated Certificate);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that the Board may establish one or more committees thereof, subject to the Bylaws;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that, subject to the rights of the holders of any outstanding class of preferred stock, the number of authorized shares of any class of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), or preferred stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the outstanding shares of the Common Stock entitled to vote thereon, irrespective of the provisions of Section 242(b)(2) of the Delaware General Corporation Law (the &#8220;DGCL&#8221;); and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide for exculpation of the officers of the Company from monetary liability in certain circumstances, pursuant to the DGCL.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, as disclosed
in Item 5.07 below, at the Reconvened Meeting, the Company&#8217;s stockholders also approved the following substantive changes to the
Restated Certificate:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that the Board be divided into three classes of directors serving staggered three-year terms and  provide that removal of directors shall only be for cause;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">eliminate the ability of the Company&#8217;s stockholders to act by written consent without a meeting, requiring all stockholder action to be taken at an annual or special meeting of stockholders; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide that the Company&#8217;s stockholders may only adopt, amend, alter or repeal the Bylaws by the affirmative vote of the holders of at least sixty-six and two-thirds percent (66 2/3%) in voting power of the outstanding shares of Common Stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accordingly, on December 29, 2023,
following the Reconvened Meeting, the Company filed the Restated Certificate with the Secretary of State of the State of Delaware implementing
the approved changes and the&#160;Restated&#160;Certificate&#160;was effective immediately upon filing (the &#8220;Effective Time&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the change
to the Restated Certificate to classify the Board, as described in the Company&#8217;s definitive proxy statement on Schedule 14A filed
with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on October 26, 2023 (the &#8220;Proxy Statement&#8221;), the classes
of the Board are designated as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Emer Leahy is a Class I director, and her initial term will expire at the 2024 Annual Meeting of Stockholders of the Company;</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simon
Dumesnil and Alfred Novak are Class II directors, and their initial terms will expire at the 2025 Annual Meeting of Stockholders of the
Company; and</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Tiago Reis Marques and Prof. Lawrence Steinman are Class III directors, and their initial terms will expire at the 2026 Annual Meeting
of Stockholders of the Company.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;Additionally, as disclosed
in a Current Report on Form 8-K filed with the SEC on December 28, 2023, the Company had previously filed a Certificate of Amendment to
the Certificate (the &#8220;Certificate of Amendment&#8221;) with the Secretary of State of the State of Delaware to effect a reverse
stock split of Common Stock at a ratio of one-for-twenty (1:20) (the &#8220;Reverse Split&#8221;) as of 12:01 a.m. on January 2, 2024
(the &#8220;Reverse Split Effective Time&#8221;). On December 29, 2023, in connection with its filing of the Restated Certificate, the
Company also made certain clerical filings (the &#8220;Corrective Filings&#8221;), so as to terminate and refile the Certificate of Amendment
and thereby effect the Reverse Split, still at the Reverse Split Effective Time, as an amendment to the Restated Certificate instead of
the Certificate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">The foregoing description
of the Restated Certificate and the Corrective Filings is qualified in its entirety by reference to the full text of such documents, which
are filed as Exhibits 3.1, 3.3 and 3.4 to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><i>Amended and Restated Bylaws</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The Board had previously approved
an amendment and restatement of the Bylaws (as so amended and restated, the &#8220;Restated Bylaws&#8221;), to be effective upon the Effective
Time, to be consistent with any changes to the Certificate adopted and approved by the Company&#8217;s stockholders at the Reconvened
Meeting. Additionally, to improve the overall quality of the Company&#8217;s corporate governance, several other changes have been made
to the Bylaws, including but not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clarifying that a stockholders meeting, special or annual, may be adjourned by the Board, the chairman of the meeting or, if directed to be voted on by the chairman of the meeting, by the Company&#8217;s stockholders present or represented at the meeting, although less than a quorum;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adding an exclusive forum provision providing that unless the Company consents in writing to the selection of an alternative forum, a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware) shall be the sole and exclusive forum for certain legal actions and proceedings;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clarifying that a stockholder&#8217;s notice of a nomination or other business to be brought before an annual meeting of stockholders, to be timely, must, if such annual meeting is more than thirty (30) days before or more than seventy (70) days after the anniversary of the preceding year&#8217;s annual meeting, notice by the stockholder must be delivered not earlier than the close of business on the one hundred twentieth (120th) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made by the Company), changing the specified period from 60 days after such anniversary date to 70 days after such anniversary date;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring that any stockholder director nominations include the information required by Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and be accompanied by certain consents, information, acknowledgements and representations of each nominee;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">clarifying the Board&#8217;s authority to delegate to committees and such committees&#8217; procedural requirements; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">various other administrative, technical, stylistic, modernizing, clarifying and conforming changes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">This description of the Restated
Bylaws is qualified in its entirety by reference to the full text of the Restated Bylaws, which is filed as Exhibit 3.2 to this Current
Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.07 Submission of Matters to a Vote of Security Holders. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On December 29, 2023, the Company
reconvened and completed the Reconvened Meeting, which had been partially adjourned on December 19, 2023 and further adjourned on December
28, 2023. At the Reconvened Meeting, the Company&#8217;s stockholders voted on the four proposals listed below. These proposals are described
in detail in the Proxy Statement. Of the 20,836,623 shares of Common Stock outstanding and entitled to vote at the Reconvened Meeting,
15,366,446 shares of Common Stock were represented in person or by proxy at the Reconvened Meeting, thereby constituting a quorum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The voting results on each of
the proposals acted upon at the Reconvened Meeting are set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>Proposal 4</b> related to the
adoption and approval of the Restated Certificate, which Restated Certificate would also include the below amendments to effect material
changes set forth as separate Proposals 5(A) through 5(C). Proposal 4 was approved by a majority of the voting power of the issued and
outstanding shares of Common Stock that are entitled to vote on the proposal, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">FOR</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">AGAINST</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABSTAIN</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">BROKER NON-VOTES</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center">10,473,045</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">1,529,403</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">449,021</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">2,914,977</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>Proposal 5(A)</b> related to
the adoption and approval of an amendment to the Certificate to classify the Board into three classes with staggered three-year terms
and to provide that removal of directors shall only be for cause. Proposal 5(A) was approved by a majority of the voting power of the
issued and outstanding shares of Common Stock that are entitled to vote on the proposal, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">FOR</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">AGAINST</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">ABSTAIN</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">BROKER NON-VOTES</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 23%; text-align: center">10,655,430</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">1,795,048</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">991</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 22%; text-align: center">2,914,977</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>Proposal 5(B)</b> related to
the adoption and approval of an amendment to the Certificate to prohibit the ability of stockholders to take action by written consent.
Proposal 5(B) was approved by a majority of the voting power of the issued and outstanding shares of Common Stock that are entitled to
vote on the proposal, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAINST</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABSTAIN</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BROKER NON-VOTES</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,422,421</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,006,529</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,519</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,914,977</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>Proposal 5(C) </b>related to
the adoption and approval of an amendment to the Certificate to require a vote of the holders of at least two-thirds of all then-outstanding
shares of Common Stock to amend Bylaws. Proposal 5(C) was approved by a majority of the voting power of the issued and outstanding shares
of Common Stock that are entitled to vote on the proposal, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAINST</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABSTAIN</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BROKER NON-VOTES</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,473,072</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,513,065</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,332</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,914,977</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea190803ex3-1_pasithea.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp., dated December 29, 2023.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea190803ex3-2_pasithea.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Bylaws of Pasithea Therapeutics Corp., dated December 29, 2023.</span></a></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><a href="ea190803ex3-3_pasithea.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Termination of Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp., dated December 29, 2023.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea190803ex3-4_pasithea.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Pasithea Therapeutics Corp., dated December 29, 2023.</span></a></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PASITHEA THERAPEUTICS CORP.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: January 2, 2024</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Tiago Reis Marques</i></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiago Reis Marques</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJydkMFOAjEQhp+Ad5hsPBJoi8Rkb7pBYgTdAEGvdZmVht3OZtpFeCTf0m4X48WLNk2ayfz/N/80SYbJnO5NhQyvd6sFbLBuKu0RVlgioy0wKLKHxxTCu8J34zxr62P5bcwoeDB4piMldWhE6dE43KUg1Xgix2oC4iadXkO+TAZdPyNbmh1ab3QF2u4gZ2rYoNd87gkbfSJL9TmO2iI7QzbgRqJvf4ISUsETHfUH8cHBYpElg2E8g2TO1DZBNTt5tJ0TZhXWYZzr3T83pila56lOXzR3y7kN5S0Xe+1wvdeM7rkMK9Zk156KQ655q6sWxUgIIXPkqFli/YYcUFIoJcXtJeU3ETxBc2GCi1CgEnosRO4QGs1w7NBw1cOhCb8b1b+E/W+kP8/8Aq96piU= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea190803ex3-1_pasithea.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PASITHEA THERAPEUTICS CORP., DATED DECEMBER 29, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED<BR>
CERTIFICATE OF INCORPORATION OF<BR>
PASITHEA THERAPEUTICS CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Pasithea Therapeutics Corp.
(the &ldquo;<U>Company</U>&rdquo;), a corporation organized and existing under the General Corporation Law of the State of Delaware (the
&ldquo;<U>DGCL</U>&rdquo;), hereby certifies as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.   The
name of the Company is Pasithea Therapeutics Corp. The date of the filing of the Company&rsquo;s original certificate of incorporation
with the Secretary of State of the State of Delaware was May&nbsp;19, 2020. The Company filed an amended and restated certificate of incorporation
with the Secretary of State of the State of Delaware on April&nbsp;8, 2021 (the &ldquo;<U>Amended and Restated Certificate</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.   This
Second Amended and Restated Certificate of Incorporation, which both restates and amends the provisions of the Amended and Restated Certificate,
has been duly adopted by the Company in accordance with Sections 242 and 245 of the DGCL and has been adopted by the requisite vote of
the stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.   The
text of the Amended and Restated Certificate is hereby amended and restated in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE&nbsp;I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The name of the corporation
is &ldquo;Pasithea Therapeutics Corp.&rdquo; (hereinafter called the &ldquo;<U>Company</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The address of the Company&rsquo;s
registered office in the State of Delaware is 8 The Green STE A, Dover, Kent County, 19901. The name of its registered agent at such address
is A Registered Agent, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the Company
is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware
or any applicable successor act thereto, as the same may be amended from time to time (the &ldquo;<U>DGCL</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) <U>Classes of
Stock</U>. The total number of shares of all classes of capital stock that the Company is authorized to issue is five hundred
million (500,000,000) shares which shall be divided into two classes of stock to be designated &ldquo;<U>Common Stock</U>&rdquo; and
&ldquo;<U>Preferred Stock</U>&rdquo;. The total number of shares of Common Stock that the Company is authorized to issue is four
hundred ninety five million (495,000,000) shares, par value $0.0001 per share. The total number of shares of Preferred Stock that
the Corporation is authorized to issue is five million (5,000,000) shares, par value $0.0001 per share. Subject to the rights of the
holders of any series of Preferred Stock, the number of authorized shares of any of the Common Stock or Preferred Stock may be
increased or decreased (but not below the number of shares thereof then outstanding) without a separate class vote of the holders of
Common Stock or Preferred Stock, irrespective of the provisions of Section&nbsp;242(b)(2)&nbsp;of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B)&nbsp;<U>Common Stock</U>.
The powers, preferences and relative participating, optional or other special rights, and the qualifications, limitations and restrictions
thereof, of the Common Stock are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.   <U>Ranking</U>.
The dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights, powers and preferences
of the holders of the Preferred Stock of any series as may be designated by the Board of Directors of the Company (the &ldquo;<U>Board</U>&rdquo;)
upon any issuance of the Preferred Stock of any series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.   <U>Voting</U>.
Except as otherwise provided by law or by the resolution or resolutions providing for the issue of any series of Preferred Stock, the
holders of outstanding shares of Common Stock shall have the exclusive right to vote for the election and removal of directors and for
all other purposes. Notwithstanding any other provision of this Second Amended and Restated Certificate of Incorporation (as the same
may be amended and/or restated from time to time, including the terms of any Preferred Stock Designation (as defined below), this &ldquo;<U>Certificate
of Incorporation</U>&rdquo;) to the contrary, the holders of Common Stock shall not be entitled to vote on any amendment to this Certificate
of Incorporation (including any Preferred Stock Designation) that relates solely to the terms of one or more outstanding series of Preferred
Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other
such series, to vote thereon pursuant to this Certificate of Incorporation (including any Preferred Stock Designation) or the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.   <U>Dividends</U>.
Subject to the rights of the holders of Preferred Stock, holders of shares of Common Stock shall be entitled to receive such dividends
and distributions and other distributions in cash, stock or property of the Company when, as and if declared thereon by the Board from
time to time out of assets or funds of the Company legally available therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.   <U>Liquidation</U>.
Subject to the rights of the holders of Preferred Stock, shares of Common Stock shall be entitled to receive the assets and funds of the
Corporation available for distribution in the event of any liquidation, dissolution or winding up of the affairs of the Corporation, whether
voluntary or involuntary. A liquidation, dissolution or winding up of the affairs of the Corporation, as such terms are used in this Section
B(4), shall not be deemed to be occasioned by or to include any other transaction, including any consolidation or merger of the Corporation
with or into any other person or a sale, lease, exchange or conveyance of all or a part of its assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C)&nbsp;<U>Preferred Stock</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shares of Preferred Stock may
be issued from time to time in one or more series. The Board is hereby authorized to provide by resolution or resolutions from time to
time for the issuance, out of the unissued shares of Preferred Stock, of one or more series of Preferred Stock, without stockholder approval,
by filing a certificate pursuant to the applicable law of the State of Delaware (the &ldquo;<U>Preferred Stock Designation</U>&rdquo;),
setting forth such resolution and, with respect to each such series, establishing the number of shares to be included in such series,
and fixing the voting powers, full or limited, or no voting power of the shares of such series, and the designation, preferences and relative,
participating, optional or other special rights, if any, of the shares of each such series and any qualifications, limitations or restrictions
thereof. The powers, designation, preferences and relative, participating, optional and other special rights of each series of Preferred
Stock, and the qualifications, limitations and restrictions thereof, if any, may differ from those of any and all other series at any
time outstanding. The authority of the Board with respect to each series of Preferred Stock shall include, but not be limited to, the
determination of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(a)  the
designation of the series, which may be by distinguishing number, letter or title;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(b)  the
number of shares of the series, which number the Board may thereafter (except where otherwise provided in the Preferred Stock Designation)
increase or decrease (but not below the number of shares thereof then outstanding);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(c)  the
amounts or rates at which dividends will be payable on, and the preferences, if any, of shares of the series in respect of dividends,
and whether such dividends, if any, shall be cumulative or noncumulative;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(d)  the
dates on which dividends, if any, shall be payable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(e)  the
redemption rights and price or prices, if any, for shares of the series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(f)  the
terms and amount of any sinking fund, if any, provided for the purchase or redemption of shares of the series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(g)  the
amounts payable on, and the preferences, if any, of shares of the series in the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(h)  whether
the shares of the series shall be convertible into or exchangeable for, shares of any other class or series, or any other security, of
the Company or any other corporation, and, if so, the specification of such other class or series or such other security, the conversion
or exchange price or prices or rate or rates, any adjustments thereof, the date or dates at which such shares shall be convertible or
exchangeable and all other terms and conditions upon which such conversion or exchange may be made;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(i)  restrictions
on the issuance of shares of the same series or any other class or series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(j)  the
voting powers, if any, of the holders of shares of the series generally or upon specified events; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 96pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">(k)  any
other powers, preferences and relative, participating, optional or other special rights of each series of Preferred Stock, and any qualifications,
limitations or restrictions thereof, all as may be determined from time to time by the Board and stated in the resolution or resolutions
providing for the issuance of such Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the generality
of the foregoing, the resolutions providing for issuance of any series of Preferred Stock may provide that such series shall be superior
or rank equally or be junior to any other series of Preferred Stock to the extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE&nbsp;V</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Article&nbsp;V is inserted
for the management of the business and for the conduct of the affairs of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A)&nbsp;<U>General Powers</U>.
The business and affairs of the Company shall be managed by or under the direction of the Board, except as otherwise provided by this
Certificate of Incorporation or the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B)&nbsp;<U>Number of Directors;
Election of Directors</U>. Subject to the rights of holders of any series of Preferred Stock to elect directors, the number of the directors
of the Company shall be fixed from time to time solely by resolution of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C)&nbsp;<U>Classes of Directors</U>.
Subject to the rights of holders of any series of Preferred Stock to elect directors, the Board shall be divided into three classes, designated
Class&nbsp;I, Class&nbsp;II and Class&nbsp;III.&nbsp;Each class shall consist, as nearly as may be possible, of one third of the total
number of directors constituting the entire Board. The Board is authorized to assign members of the Board already in office to Class&nbsp;I,
Class&nbsp;II or Class&nbsp;III at the time such classification becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(D)&nbsp;<U>Terms of Office</U>.
Subject to the rights of holders of any series of Preferred Stock to elect directors, each director shall serve for a term ending on the
date of the third annual meeting of stockholders following the annual meeting of stockholders at which such director was elected; <U>provided</U>
that each director initially assigned to Class&nbsp;I shall serve for a term expiring at the Company&rsquo;s first annual meeting of stockholders
held following the time at which the initial classification of the Board becomes effective; each director initially assigned to Class&nbsp;II
shall serve for a term expiring at the Company&rsquo;s second annual meeting of stockholders held following the time at which the initial
classification of the Board becomes effective; and each director initially assigned to Class&nbsp;III shall serve for a term expiring
at the Company&rsquo;s third annual meeting of stockholders held following the time at which the initial classification of the Board becomes
effective; provided further, that the term of each director shall continue until the election and qualification of his or her successor
and be subject to his or her earlier death, disqualification, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(E)&nbsp;<U>Vacancies</U>.
Subject to the rights of holders of any series of Preferred Stock, any newly created directorship that results from an increase in the
number of directors or any vacancy on the Board that results from the death, resignation, disqualification or removal of any director
or from any other cause shall be filled solely by the affirmative vote of a majority of the directors then in office, even if less than
a quorum, or by a sole remaining director and shall not be filled by the stockholders. Any director elected in accordance with the preceding
sentence shall, in the case of a newly created directorship, hold office for the full term of the class in which the newly created directorship
was created or, in the case of a vacancy, hold office for the remaining term of his or her predecessor and in each case until his or her
successor shall be elected and qualified, subject to his or her earlier death, disqualification, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(F)&nbsp;<U>Removal</U>. Subject
to the rights of the holders of any series of Preferred Stock, any director or the entire Board may be removed from office at any time,
but only for cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(G)&nbsp;<U>Committees</U>.
Pursuant to the Amended and Restated Bylaws of the Company (as the same may be amended and/or restated from time to time, the &ldquo;<U>Bylaws</U>&rdquo;),
the Board may establish one or more committees to which may be delegated any or all of the powers and duties of the Board to the full
extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(H)&nbsp;<U>Stockholder Nominations
and Introduction of Business</U>. Advance notice of stockholder nominations for election of directors and other business to be brought
by stockholders before a meeting of stockholders shall be given in the manner provided by the Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(I)&nbsp;<U>Preferred Stock
Directors</U>. During any period when the holders of any series of Preferred Stock have the right to elect additional directors as provided
for or fixed pursuant to the provisions of Article&nbsp;IV hereof or any Preferred Stock Designation, then upon commencement and for the
duration of the period during which such right continues: (i)&nbsp;the then otherwise total number of authorized directors of the Corporation
shall automatically be increased by such specified number of directors, and the holders of such Preferred Stock shall be entitled to elect
the additional directors so provided for or fixed pursuant to said provisions, and (ii)&nbsp;each such additional director shall serve
until such director&rsquo;s successor shall have been duly elected and qualified, or until such director&rsquo;s right to hold such office
terminates pursuant to said provisions, whichever occurs earlier, subject to his or her earlier death, disqualification, resignation or
removal. Except as otherwise provided for or fixed pursuant to the provisions of Article&nbsp;IV hereof or any Preferred Stock Designation,
whenever the holders of any series of Preferred Stock having such right to elect additional directors are divested of such right pursuant
to the provisions of such stock, the terms of office of all such additional directors elected by the holders of such stock, or elected
to fill any vacancies resulting from the death, resignation, disqualification or removal of such additional directors, shall forthwith
terminate, the person or persons serving as such additional directors shall automatically cease to be qualified to serve as a director
and shall automatically cease to be a director and the total authorized number of directors of the Corporation shall be reduced accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(J)  <U>Written
Ballot</U>. Unless and except to the extent that the Bylaws shall so require, the election of directors of the Company need not be by
written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the fullest extent permitted
by the DGCL as the same exists or as may hereafter be amended, a director or officer of the Company shall not be personally liable to
the Company or its stockholders for monetary damages for breach of fiduciary duty as a director or officer. No repeal or modification
of this Article&nbsp;VI shall apply to or have any adverse effect on any right or protection of, or any limitation of the liability of,
a director or officer of the Company existing at the time of such repeal or modification with respect to acts or omissions occurring prior
to such repeal or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company may indemnify,
and advance expenses to, to the fullest extent permitted by law, any person who was or is a party to or is threatened to be made a party
to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason
of the fact that the person is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the
Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VIII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms of any
series of Preferred Stock, any action required or permitted to be taken by the stockholders of the Company must be effected at an annual
or special meeting of the stockholders and may not be effected by consent in lieu of a meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Special meetings of stockholders
for any purpose or purposes may be called at any time by the Board, the Chairman of the Board or the Chief Executive Officer of the Company,
and may not be called by another other person or persons. Business transacted at any special meeting of stockholders shall be limited
to matters relating to the purpose or purposes stated in the notice of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;X</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby reserves
the right at any time and from time to time to amend, alter, change or repeal any provision contained in this Certificate of Incorporation,
and any other provisions authorized by the General Corporation Law may be added or inserted, in the manner now or hereafter prescribed
by the General Corporation Law, and all rights, preferences and privileges of whatsoever nature conferred on stockholders, directors or
any other persons whomsoever therein granted are subject to this reservation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In furtherance and not in limitation
of the powers conferred upon it by law, the Board is expressly authorized and empowered to adopt, amend and repeal the Bylaws. Notwithstanding
any other provision of this Certificate of Incorporation or any provision of law that might otherwise permit a lesser vote, but in addition
to any affirmative vote of the holders of any series of Preferred Stock required by law, by this Certificate of Incorporation or by any
Preferred Stock Designation, the Bylaws may also be amended, altered or repealed and new Bylaws may be adopted by the stockholders of
the Company by the affirmative vote of the holders of at least sixty-six and two-thirds percent (66 2/3%) in voting power of the outstanding
shares of capital stock of the Company entitled to vote thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of Page Intentionally Left Blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has caused this Second Amended and Restated Certificate of Incorporation to be executed by the undersigned duly authorized
officer of the Company this 29th day of December, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PASITHEA
    THERAPEUTICS CORP.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tiago Reis Marques</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tiago Reis Marques</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ea190803ex3-2_pasithea.htm
<DESCRIPTION>SECOND AMENDED AND RESTATED BYLAWS OF PASITHEA THERAPEUTICS CORP., DATED DECEMBER 29, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 3.2</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED BYLAWS<BR>
OF<BR>
Pasithea Therapeutics Corp.<BR>
a Delaware Corporation<BR>
(as amended and restated through December 29, 2023)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I<BR>
<FONT STYLE="text-transform: uppercase">STOCKHOLDERS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1   <U>Place
of Meetings</U>. All meetings of stockholders shall be held at such place, if any, as may be designated from time to time by the Board
of Directors (the &ldquo;<U>Board</U>&rdquo;) of Pasithea Therapeutics Corp. (the &ldquo;<U>Corporation</U>&rdquo;), the Chairman of the
Board or the Chief Executive Officer or, if not so designated, at the principal office of the Corporation. The Board may, in its sole
discretion, determine that a meeting shall not be held at any place, but may instead be held solely by means of remote communication in
accordance with Section 211(a)(2) of the General Corporation Law of the State of Delaware (the &ldquo;<U>DGCL</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2   <U>Annual
Meeting</U>. The annual meeting of stockholders for the election of directors to succeed those whose terms expire and for the transaction
of such other business as may properly be brought before the meeting shall be held on a date and at a time designated by the Board, the
Chairman of the Board or the Chief Executive Officer. The Company may postpone, recess, reschedule or cancel any previously scheduled
annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3   <U>Special
Meetings</U>. Special meetings of stockholders for any purpose or purposes may be called solely in the manner set forth in the Certificate
of Incorporation. The Company may postpone, recess, reschedule or cancel any previously scheduled special meeting of stockholders. Business
transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice
of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4   <U>Notice
of Meetings</U>. Except as otherwise provided by law, notice of each meeting of stockholders, whether annual or special, shall be given
not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting
as of the record date for determining the stockholders entitled to notice of the meeting. The notices of all meetings shall state the
place, if any, date and time of the meeting, the means of remote communications, if any, by which stockholders and proxyholders may be
deemed to be present in person and vote at such meeting, and the record date for determining the stockholders entitled to vote at the
meeting (if such date is different from the record date for stockholders entitled to notice of the meeting). The notice of a special meeting
shall state, in addition, the purpose or purposes for which the meeting is called.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5   <U>Voting
List</U>. The Corporation shall prepare, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders
entitled to vote at the meeting (<U>provided</U>, <U>however</U>, if the record date for determining the stockholders entitled to vote
is less than ten (10) days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day
before the meeting date), arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered
in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting,
for a period of ten (10) days ending on the day before the meeting date: (a) on a reasonably accessible electronic network, <U>provided</U>
that the information required to gain access to such list is provided with the notice of the meeting, or (b) during ordinary business
hours, at the principal place of business of the Corporation. Except as otherwise provided by law, the stock ledger shall presumptively
determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.6   <U>Quorum</U>.
Except as otherwise provided by law, the Certificate of Incorporation or these Bylaws, the presence of holders of one-third of the voting
power of the shares of the capital stock of the Corporation issued and outstanding and entitled to vote at the meeting, whether present
in person, present by means of remote communication in a manner, if any, authorized by the Board in its sole discretion, or represented
by proxy, shall constitute a quorum for the transaction of business; <U>provided</U>, <U>however</U>, that where a separate vote by a
class or classes or series of capital stock is required by law or the Certificate of Incorporation, the presence of the holders of a majority
in voting power of the outstanding shares of such class or classes or series, whether present in person, present by means of remote communication
in a manner, if any, authorized by the Board in its sole discretion, or represented by proxy, shall constitute a quorum entitled to take
action with respect to the vote on such matter. A quorum, once established at a meeting, shall not be broken by the withdrawal of enough
votes to leave less than a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.7   <U>Adjournments</U>.
Any meeting of stockholders, annual or special, may be adjourned from time to time to any other time and to any other place at which a
meeting of stockholders may be held under these Bylaws by the Board, the chairman of the meeting or, if directed to be voted on by the
chairman of the meeting, by the stockholders present or represented at the meeting and entitled to vote thereon, although less than a
quorum. If the adjournment is for more than thirty (30) days, a notice of the adjourned meeting shall be given to each stockholder of
record entitled to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote
is fixed for the adjourned meeting, the Board shall fix as the record date for determining stockholders entitled to notice of such adjourned
meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall
give notice of the adjourned meeting to each stockholder of record entitled to vote at the adjourned meeting as of the record date so
fixed for notice of such adjourned meeting. At the adjourned meeting, the Corporation may transact any business which might have been
transacted at the original meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.8   <U>Proxies</U>.
Each stockholder of record entitled to vote at a meeting of stockholders may vote in person (including by means of remote communications,
if any, by which stockholders may be deemed to be present in person and vote at such meeting) or may authorize another person or persons
to vote for such stockholder by a proxy executed or transmitted in a manner permitted by applicable law. No such proxy shall be voted
upon after three years from its date, unless the proxy expressly provides for a longer period. A proxy shall be irrevocable if it states
that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power.
A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary
of the Corporation a revocation of the proxy or a new proxy bearing a later date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.9   <U>Action
at Meeting</U>. When a quorum is present at any meeting, any matter other than the election of directors to be voted upon by the stockholders
at such meeting shall be decided by the a majority of the votes cast affirmatively or negatively on such matter (or if any class or series
of stock is entitled to vote as a separate class or series, then in the case of each such class or series, by a majority of the votes
cast affirmatively or negatively on such matter by the holders of such class or series of stock), except when a different vote is required
by express provision of applicable law, regulation applicable to the Corporation or its securities, the rules or regulations of any stock
exchange applicable to the Corporation, the Certificate of Incorporation or these Bylaws, in which case such express provisions shall
govern. Except as otherwise provided by the Certificate of Incorporation, at all meetings of stockholders for the election of directors
at which a quorum is present, directors shall be elected by a plurality of the votes cast. Voting at meetings of stockholders need not
be by written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.10  <U>Notice
of Stockholder Business and Nominations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A)   <U>Annual
Meetings of Stockholders</U>. (1) Nominations of persons for election to the Board and the proposal of other business to be considered
by the stockholders may be made at an annual meeting of stockholders only (a) solely with respect to the proposal of business (and not
with respect to nominations of persons for election to the Board of Directors), pursuant to the Corporation&rsquo;s notice of meeting
(or any supplement thereto), (b) by or at the direction of the Board or any committee thereof or (c) by any stockholder of the Corporation
who was a stockholder of record of the Corporation at the time the notice provided for in this Section 1.10 is delivered to the Secretary
of the Corporation, who is entitled to vote at the meeting upon such election of directors or upon such other business, as the case may
be, and who complies with the notice procedures set forth in this Section 1.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)   For
any nominations or other business to be properly brought before an annual meeting by a stockholder pursuant to clause (c) of paragraph
(A)(1) of this Section 1.10, the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation (and
must timely provide any updates or supplements to such notice at such times and in such forms provided by this Section 1.10) and any such
proposed business (other than the nominations of persons for election to the Board) must constitute a proper matter for stockholder action.
To be timely, a stockholder&rsquo;s notice shall be delivered to the Secretary at the principal executive offices of the Corporation not
later than the ninetieth (90<SUP>th</SUP>) day, nor earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>)
day, prior to the first anniversary of the preceding year&rsquo;s annual meeting (provided, however, that in the event that the date of
the annual meeting is more than thirty (30) days before or more than seventy (70) days after such anniversary date, notice by the stockholder
must be so delivered not earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>) day prior to such annual meeting
and not later than the close of business on the later of the ninetieth (90<SUP>th</SUP>) day prior to such annual meeting or the tenth
(10<SUP>th</SUP>) day following the day on which public announcement of the date of such meeting is first made by the Corporation). In
no event shall the public announcement of an adjournment, postponement or recess of an annual meeting commence a new time period (or extend
any time period) for the giving of a stockholder&rsquo;s notice as described above. The number of nominees a stockholder may nominate
for election at the annual meeting (or in the case of one or more stockholders giving the notice on behalf of a beneficial owner, the
number of nominees such stockholders may collectively nominate for election at the annual meeting on behalf of such beneficial owner)
shall not exceed the number of directors to be elected at such annual meeting. To be in proper form for purposes of this Section 1.10,
such stockholder&rsquo;s notice shall set forth: (a) as to each person whom the stockholder proposes to nominate for election as a director
(i) the name, age, business and residence address, and principal occupation or employment of the nominee, (ii) all other information relating
to such nominee that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise
required, in each case pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and the rules and regulations promulgated thereunder, (iii) a reasonably detailed description of any compensatory, payment
or other financial agreement, arrangement or understanding that such nominee has with any other person or entity other than the Corporation
including the amount of any payment or payments received or receivable thereunder, in each case in connection with candidacy or service
as a director of the Corporation, (iv) such person&rsquo;s written consent to being named in the Corporation&rsquo;s proxy statement and
associated proxy card and to serving as a director if elected, (v) all information with respect to such nominee that would be required
to be set forth in a stockholder&rsquo;s notice pursuant to this Section 1.10 if such nominee were the stockholder giving notice hereunder,
(vi) a questionnaire completed and signed by such person (in the form to be provided by the Secretary of the Corporation upon written
request of any stockholder of record within ten (10) days of such request) with respect to the background and qualification of such proposed
nominee and the background of any other person or entity on whose behalf the nomination is being made and (vii) and a written representation
and agreement (in the form to be provided by the Secretary of the Corporation upon written request of any stockholder of record within
ten (10) days of such request) that such proposed nominee (A) is not and will not become a party to any agreement, arrangement or understanding
with, and has not given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director
of the Corporation, will act or vote on any issue or question that has not been disclosed to the Corporation or that could limit or interfere
with such proposed nominee&rsquo;s fiduciary duties under applicable law, (B) is not and will not become a party to any agreement, arrangement
or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement
or indemnification in connection with service or action as a director that has not been disclosed to the Corporation, and (C) would be
in compliance, if elected as a director of the Corporation, and will comply with, all applicable publicly disclosed corporate governance,
code of conduct and ethics, conflict of interest, confidentiality, corporate opportunities, trading and any other policies and guidelines
of the Corporation applicable to directors; (b) as to any other business that the stockholder proposes to bring before the meeting, (i)
a brief description of the business desired to be brought before the meeting, (ii) the text of the proposal or business (including the
text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the Bylaws of the
Corporation, the language of the proposed amendment), (iii) the reasons for conducting such business at the meeting, (iv) any direct or
indirect material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made
and any other person or persons with whom such stockholder or beneficial owner, if any, has any agreement, arrangement or understanding
in connection with such proposal and (v) such other information relating to any proposed item of business as the Corporation may reasonably
require to determine whether such proposed item of business is a proper matter for stockholder action; and (c) as to the stockholder giving
the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such stockholder,
as they appear on the Corporation&rsquo;s books, and of such beneficial owner, (ii) the class or series and number of shares of capital
stock of the Corporation which are, directly or indirectly, owned beneficially (within the meaning of Rule 13d-3 under the Exchange Act)
or of record by such stockholder and such beneficial owner (provided, that such stockholder and the beneficial owner, if any, on whose
behalf the nomination or proposal is made shall in all events be deemed to beneficially own any shares of any class or series and number
of shares of capital stock of the Corporation as to which such stockholder or beneficial owner, if any, has a right to acquire beneficial
ownership at any time in the future), (iii) a description of any agreement, arrangement or understanding with respect to the nomination
or proposal between or among such stockholder and/or such beneficial owner, any of their respective affiliates or associates, and any
others acting in concert with any of the foregoing, including, in the case of a nomination, the nominee (each of the foregoing, a &ldquo;Stockholder
Associated Person&rdquo;), (including the names of each such Stockholder Associated Person), (iv) a description of any agreement, arrangement
or understanding (including any derivative or short positions, profit interests, options, warrants, convertible securities, stock appreciation
or similar rights, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the stockholder&rsquo;s
notice by, or on behalf of, such stockholder and such beneficial owners, whether or not such instrument or right shall be subject to settlement
in underlying shares of capital stock of the Corporation, the effect or intent of which is to mitigate loss to, manage risk or benefit
of share price changes for, or increase or decrease the voting power of, such stockholder or such beneficial owner, with respect to securities
of the Corporation, (v) a representation that the stockholder is a holder of record of stock of the Corporation entitled to vote at such
meeting upon such business or nomination, as the case may be, and intends to appear in person or by proxy at the meeting to propose such
business or nomination, (vi) a representation whether such stockholder or any Stockholder Associated Person intends or is part of a group
which intends (a) to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding
capital stock required to approve or adopt the proposal or elect the nominee, (b) otherwise to solicit proxies or votes from stockholders
in support of such proposal or nomination or (c) to solicit proxies in support of any proposed nominee in accordance with Rule 14a-19
promulgated under the Exchange Act, and (vii) any other information relating to such stockholder and beneficial owner, if any, required
to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable,
the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange
Act and the rules and regulations promulgated thereunder. The foregoing notice requirements of this paragraph (A) of this Section 1.10
shall be deemed satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the Corporation
of his, her or its intention to present a proposal<B>&nbsp;</B>at an annual meeting in compliance with applicable rules and regulations
promulgated under the Exchange Act and such stockholder&rsquo;s proposal has been included in a proxy statement that has been prepared
by the Corporation to solicit proxies for such annual meeting. The Corporation may require any proposed nominee or stockholder seeking
to nominate a director candidate or bring other business before an annual meeting to furnish such other information as the Corporation
may reasonably request, including, without limitation, for the purpose of determining the eligibility of such proposed nominee to serve
as a director of the Corporation or the independence of such proposed nominee. If requested by the Corporation, the information required
by this Section 1.10 shall be supplemented by such stockholder of record in writing to the Secretary of the Corporation at the principal
executive offices of the Corporation not later than ten (10) days after any record date for the meeting to disclose such information as
of such record date; provided, that no such update or supplement shall cure or affect the accuracy (or inaccuracy) of any representations
made by any stockholder or Stockholder Associated Person or the validity (or invalidity) of any nomination or proposal that failed to
comply with this Section 1.10 or is rendered invalid as a result of any inaccuracy therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)   Notwithstanding
anything in the second sentence of paragraph (A)(2) of this Section 1.10 to the contrary, in the event that the number of directors to
be elected to the Board at the annual meeting is increased effective after the time period for which nominations would otherwise be due
under paragraph (A)(2) of this Section 1.10 and there is no public announcement by the Corporation naming the nominees for the additional
directorships at least one hundred (100) days prior to the first anniversary of the preceding year&rsquo;s annual meeting, a stockholder&rsquo;s
notice required by this Section 1.10 shall also be considered timely, but only with respect to nominees for the additional directorships,
if it shall be delivered to the Secretary at the principal executive offices of the Corporation not later than the close of business on
the tenth (10<SUP>th</SUP>) day following the day on which such public announcement is first made by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B)   <U>Special
Meetings of Stockholders</U>. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before
the meeting pursuant to the Corporation&rsquo;s notice of meeting. Nominations of persons for election to the Board may be made at a special
meeting of stockholders at which directors are to be elected pursuant to the Corporation&rsquo;s notice of meeting (1) by or at the direction
of the Board or any committee thereof or (2) provided that the Board has determined that directors shall be elected at such meeting, by
any stockholder of the Corporation who is a stockholder of record at the time the notice provided for in this Section 1.10 is delivered
to the Secretary of the Corporation, who is entitled to vote at the meeting and upon such election and who complies with the notice procedures
set forth in this Section 1.10. The number of nominees a stockholder may nominate for election at the special meeting at which directors
are to be elected (or in the case of one or more stockholders giving the notice on behalf of a beneficial owner, the number of nominees
such stockholders may collectively nominate for election at such special meeting on behalf of such beneficial owner) shall not exceed
the number of directors to be elected at such special meeting. In the event the Corporation calls a special meeting of stockholders for
the purpose of electing one or more directors to the Board, any such stockholder entitled to vote in such election of directors may nominate
a person or persons (as the case may be) for election to such position(s) as specified in the Corporation&rsquo;s notice of meeting, if
the stockholder&rsquo;s notice required by paragraph (A)(2) of this Section 1.10 shall be delivered to the Secretary at the principal
executive offices of the Corporation not earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>) day prior
to such special meeting and not later than the close of business on the later of the ninetieth (90<SUP>th</SUP>) day prior to such special
meeting or the tenth (10<SUP>th</SUP>) day following the day on which the public announcement is first made of the date of the special
meeting and of the nominees proposed by the Board to be elected at such meeting. In no event shall the public announcement of an adjournment,
postponement or recess of a special meeting commence a new time period (or extend any time period) for the giving of a stockholder&rsquo;s
notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C)   <U>General</U>.
(1) Except as otherwise expressly provided in any applicable rule or regulation promulgated under the Exchange Act, only such persons
who are nominated in accordance with the procedures set forth in this Section 1.10 shall be eligible to be elected at an annual or special
meeting of stockholders of the Corporation to serve as directors and only such business shall be conducted at a meeting of stockholders
as shall have been brought before the meeting in accordance with the procedures set forth in this Section 1.10. Except as otherwise provided
by law, the chairman of any meeting of stockholders (and, in advance of any meeting of stockholders, the Board) shall have the power and
duty (a) to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case
may be, in accordance with the procedures set forth in this Section 1.10 (including whether the stockholder or beneficial owner, if any,
on whose behalf the nomination or proposal is made, solicited (or is part of a group which solicited) or did not so solicit, as the case
may be, proxies or votes in support of such stockholder&rsquo;s nominee or proposal in compliance with such stockholder&rsquo;s representation
as required by clause (A)(2)(c)(vi) of this Section 1.10) and (b) if any proposed nomination or business was not made or proposed in compliance
with this Section 1.10, to declare that such nomination shall be disregarded or that such proposed business shall not be transacted. Notwithstanding
the foregoing provisions of this Section 1.10, unless otherwise required by law, if the stockholder (or a qualified representative of
the stockholder) does not appear at the annual or special meeting of stockholders of the Corporation to present a nomination or proposed
business (including, without limitation, any nominee that is not part of the Corporation&rsquo;s slate of nominees or any proposed business
included in the Corporation&rsquo;s proxy statement, notice of meeting or other proxy materials or any supplement thereto pursuant to
Rule 14-19 or 14a-8 promulgated under the Exchange Act), such nomination shall be disregarded and such proposed business shall not be
transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section
1.10, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of
such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder
to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission,
or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders. Notwithstanding anything to the
contrary in these Bylaws, unless otherwise required by law, if any stockholder or Stockholder Associated Person (i) provides notice pursuant
to Rule 14a-19(b) promulgated under the Exchange Act with respect to any proposed nominee and (ii) subsequently fails to comply with the
requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) promulgated under the Exchange Act (or fails to timely provide reasonable evidence
sufficient to satisfy the Corporation that such stockholder has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange
Act in accordance with the following sentence), then the nomination of each such proposed nominee shall be disregarded, notwithstanding
that proxies or votes in respect of the election of such proposed nominees may have been received by the Corporation (which proxies and
votes shall be disregarded). Upon request by the Corporation, if any stockholder or Stockholder Associated Person provides notice pursuant
to Rule 14a-19(b) promulgated under the Exchange Act, such stockholder shall deliver to the Corporation, no later than five (5) business
days prior to the applicable meeting, reasonable evidence that it or such Stockholder Associated Person has met the requirements of Rule
14a-19(a)(3) promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2)  For
purposes of this Section 1.10, &ldquo;public announcement&rdquo; shall include disclosure in a press release reported by the Dow Jones
News Service, Associated Press or other national news service or in a document publicly filed by the Corporation with the Securities and
Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 82pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3)  Notwithstanding
the foregoing provisions of this Section 1.10, a stockholder shall also comply with all applicable requirements of the Exchange Act and
the rules and regulations promulgated thereunder with respect to the matters set forth in this Section 1.10; provided however, that any
references in these Bylaws to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit
any requirements applicable to nominations or proposals as to any other business to be considered pursuant to this Section 1.10 (including
paragraphs (A)(1)(c) and (B) hereof), and compliance with paragraphs (A)(1)(c) and (B) of this Section 1.10 shall be the exclusive means
for a stockholder to make nominations or submit other business (other than, as provided in the penultimate sentence of (A)(2), business
other than nominations brought properly under and in compliance with Rule 14a-8 of the Exchange Act, as may be amended from time to time).
Nothing in this Section 1.10 shall be deemed to affect any rights (a) of stockholders to request inclusion of proposals (other than nominations)
in the Corporation&rsquo;s proxy statement pursuant to applicable rules and regulations promulgated under the Exchange Act or (b) of the
holders of any series of Preferred Stock to elect directors pursuant to any applicable provisions of the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5pt; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.11     <U>Conduct
of Meetings; Inspectors of Election</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A)   Meetings
of stockholders shall be presided over by the Chairman of the Board, if any, or in the Chairman&rsquo;s absence by the Vice Chairman of
the Board, if any, or in the Vice Chairman&rsquo;s absence by the Chief Executive Officer, or in the Chief Executive Officer&rsquo;s absence,
by the President, or in the President&rsquo;s absence by a Vice President, or in the absence of all of the foregoing persons by a chairman
designated by the Board. The Secretary shall act as secretary of the meeting, but in the Secretary&rsquo;s absence the chairman of the
meeting may appoint any person to act as secretary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B)   The
Board may adopt by resolution such rules, regulations and procedures for the conduct of any meeting of stockholders of the Corporation
as it shall deem appropriate including, without limitation, such guidelines and procedures as it may deem appropriate regarding the participation
by means of remote communication of stockholders and proxyholders not physically present at a meeting. Except to the extent inconsistent
with such rules, regulations and procedures as adopted by the Board, the chairman of any meeting of stockholders shall have the right
and authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe such rules, regulations and procedures
and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations
or procedures, whether adopted by the Board or prescribed by the chairman of the meeting, may include, without limitation, the following:
(i) the establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting
and the safety of those present; (iii) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation,
their duly authorized and constituted proxies or such other persons as shall be determined; (iv) restrictions on entry to the meeting
after the time fixed for the commencement thereof; and (v) limitations on the time allotted to questions or comments by participants.
Unless and to the extent determined by the Board or the chairman of the meeting, meetings of stockholders shall not be required to be
held in accordance with the rules of parliamentary procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C)   The
chairman of the meeting shall announce at the meeting when the polls for each matter to be voted upon at the meeting will be opened and
closed. After the polls close, no ballots, proxies or votes or any revocations or changes thereto may be accepted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(D)   The
Corporation may, and if required by law, shall, in advance of any meeting of stockholders, appoint one or more inspectors of election
to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to replace
any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairman of the meeting
shall appoint one or more inspectors to act at the meeting. Unless otherwise required by law, inspectors may be officers, employees, agents
or representatives of the Corporation. Each inspector, before entering upon the discharge of such inspector&rsquo;s duties, shall take
and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of such inspector&rsquo;s
ability. The inspector shall have the duties prescribed by law and, when the vote is completed, shall certify their determination of the
result of the vote taken and of such other facts as may be required by law. Every vote taken by ballots shall be counted by a duly appointed
inspector or duly appointed inspectors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE II<BR>
<FONT STYLE="text-transform: uppercase">DIRECTORS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1   <U>General
Powers</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board, who may exercise all
of the powers of the Corporation except as otherwise provided by law or the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2   <U>Number,
Election; Term and Qualification</U>. The total number of directors constituting the Board shall be as fixed in, or in the manner provided
by, the Certificate of Incorporation. Election of directors need not be by written ballot. The term of office of each director shall be
as specified in the Certificate of Incorporation. Directors need not be stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3   <U>Chairman
of the Board; Vice Chairman of the Board</U>. The Board may appoint from its members a Chairman of the Board and a Vice Chairman of the
Board, neither of whom need be an employee or officer of the Corporation. If the Board appoints a Chairman of the Board, such Chairman
shall perform such duties and possess such powers as are assigned by the Board and, if the Chairman of the Board is also designated as
the Corporation&rsquo;s Chief Executive Officer, shall have the powers and duties of the Chief Executive Officer prescribed in Section
3.7 of these Bylaws. If the Board appoints a Vice Chairman of the Board, such Vice Chairman shall perform such duties and possess such
powers as are assigned by the Board. Unless otherwise provided by the Board, the Chairman of the Board or, in the Chairman&rsquo;s absence,
the Vice Chairman of the Board, if any, shall preside at all meetings of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4   <U>Quorum</U>.
The greater of (a) a majority of the directors at any time in office and (b) one-third of the whole Board shall constitute a quorum of
the Board. If at any meeting of the Board there shall be less than a quorum, a majority of the directors present may adjourn the meeting
from time to time without further notice other than announcement at the meeting, until a quorum shall be present.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.5   <U>Action
at Meeting</U>. Every act or decision done or made by a majority of the directors present at a meeting duly held at which a quorum is
present shall be regarded as the act of the Board, unless a greater number is required by law, the Certificate of Incorporation or these
Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.6   <U>Removal</U>.
Subject to the rights of holders of any series of Preferred Stock, directors of the Corporation may be removed only as expressly provided
in the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.7   <U>Newly
Created Directorships; Vacancies</U>. Any newly created directorship that results from an increase in the number of directors or any vacancy
on the Board that results from the death, disability, resignation, disqualification or removal of any director or from any other cause
shall be filled in accordance with the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.8   <U>Resignation</U>.
Any director may resign by delivering a resignation in writing or by electronic transmission to the Corporation at its principal office
or to the Chairman of the Board, the Chief Executive Officer, the President or the Secretary. Such resignation shall be effective upon
delivery unless it is specified to be effective at some later time or upon the happening of some later event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.9   <U>Regular
Meetings</U>. Regular meetings of the Board may be held without notice at such time and place as shall be determined from time to time
by the Board; <U>provided</U> that any director who is absent when such a determination is made shall be given notice of the determination.
A regular meeting of the Board may be held without notice immediately after and at the same place as the annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.10  <U>Special
Meetings</U>. Special meetings of the Board may be called by the Chairman of the Board, the Chief Executive Officer, the affirmative vote
of a majority of the directors then in office, or by one director in the event that there is only a single director in office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.11  <U>Notice
of Special Meetings</U>. Notice of the date, place and time of any special meeting of the Board shall be given to each director (a) in
person or by telephone at least twenty-four (24) hours in advance of the meeting, (b) by sending written notice by reputable overnight
courier, telecopy, electronic mail, facsimile or other means of electronic transmission, or delivering written notice by hand, to such
director&rsquo;s last known business, home or means of electronic transmission address at least twenty-four (24) hours in advance of the
meeting, or (c) by sending written notice by first-class mail to such director&rsquo;s last known business or home address at least seventy-two
(72) hours in advance of the meeting. Such notice may be given by the Secretary or by the Chairman of the Board, the Chief Executive Officer
or one of the directors calling the meeting. A notice or waiver of notice of a meeting of the Board need not specify the purposes of the
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.12  <U>Meetings
by Conference Communications Equipment</U>. Directors may participate in meetings of the Board or any committee thereof by means of conference
telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation
by such means shall constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.13  <U>Action
by Consent</U>. Any action required or permitted to be taken at any meeting of the Board or of any committee thereof may be taken without
a meeting, if all members of the Board or committee, as the case may be, consent to the action in writing or by electronic transmission.
After an action is taken, the consent or consents relating thereto shall be filed with the minutes of proceedings of the Board, or the
committee thereof, in the same paper or electronic form as the minutes are maintained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.14  <U>Committees</U>.
The Board may designate one or more committees, each committee to consist of one or more of the directors of the Corporation with such
lawfully delegable powers and duties as the Board thereby confers, to serve at the pleasure of the Board. The Board may designate one
or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee.
In the absence or disqualification of a member of a committee, the member or members of the committee present at any meeting and not disqualified
from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at
the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the
Board and subject to the provisions of law, shall have and may exercise all the powers and authority of the Board in the management of
the business and affairs of the Corporation and may authorize the seal of the Corporation to be affixed to all papers which may require
it. Each such committee shall keep minutes and make such reports as the Board may from time to time request. Except as otherwise provided
in the Certificate of Incorporation, these Bylaws, or the resolution of the Board designating the committee, a committee may create one
or more subcommittees, each subcommittee to consist of one or more members of the committee, and delegate to a subcommittee any or all
of the powers and authority of the committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE III<BR>
<FONT STYLE="text-transform: uppercase">OFFICERS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1   <U>Titles</U>.
The officers of the Corporation may consist of a Chief Executive Officer, a President, a Chief Financial Officer, a Treasurer and a Secretary
and such other officers with such other titles as the Board shall from time to time determine. The Board may appoint such other officers,
including one or more Vice Presidents and one or more Assistant Treasurers or Assistant Secretaries, as it may deem appropriate from time
to time. The only individuals who shall be considered the officers of the Corporation shall be those individuals who have been appointed
or elected as an officer of the Corporation by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2   <U>Election</U>.
The officers of the Corporation shall be elected by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3   <U>Qualification</U>.
No officer need be a stockholder. Any two or more offices may be held by the same person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4   <U>Tenure</U>.
Except as otherwise provided by law, by the Certificate of Incorporation or by these Bylaws, each officer shall hold office until such
officer&rsquo;s successor is duly elected and qualified, unless a different term is specified in the resolution electing or appointing
such officer, or until such officer&rsquo;s earlier death, resignation, disqualification or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5   <U>Resignation
and Removal</U>. Any officer may resign by delivering a resignation in writing or by electronic transmission to the Corporation at its
principal office or to the Board, the Chief Executive Officer, the President or the Secretary. Such resignation shall be effective upon
receipt unless it is specified to be effective at some later time or upon the happening of some later event. Any officer may be removed
at any time, with or without cause, by the affirmative vote of a majority of the directors then in office. Except as the Board may otherwise
determine, no officer who resigns or is removed shall have any right to any compensation as an officer for any period following such officer&rsquo;s
resignation or removal, or any right to damages on account of such removal, whether such officer&rsquo;s compensation be by the month
or by the year or otherwise, unless such compensation is expressly provided for in a duly authorized agreement with the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.6   <U>Vacancies</U>.
The Board may fill any vacancy occurring in any office for any reason and may, in its discretion, leave unfilled, for such period as it
may determine, any offices. Each such successor shall hold office for the unexpired term of such officer&rsquo;s predecessor and until
a successor is duly elected and qualified, or until such officer&rsquo;s earlier death, resignation, disqualification or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.7   <U>President;
Chief Executive Officer</U>. Unless the Board has designated another person as the Corporation&rsquo;s Chief Executive Officer, the President
shall be the Chief Executive Officer of the Corporation. The Chief Executive Officer shall have general charge and supervision of the
business of the Corporation subject to the direction of the Board, and shall perform all duties and have all powers that are commonly
incident to the office of chief executive or that are delegated to such officer by the Board. The President shall perform such other duties
and shall have such other powers as the Board or the Chief Executive Officer (if the President is not the Chief Executive Officer) may
from time to time prescribe. In the event of the absence, inability or refusal to act of the Chief Executive Officer or the President
(if the President is not the Chief Executive Officer), the Vice President (or if there shall be more than one, the Vice Presidents in
the order determined by the Board) shall perform the duties of the Chief Executive Officer and when so performing such duties shall have
all the powers of and be subject to all the restrictions upon the Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.8   <U>Vice
Presidents/Other Officers</U>. Each Vice President and any other officer designated by the Board shall perform such duties and possess
such powers as the Board or the Chief Executive Officer may from time to time prescribe. The Board may assign to any Vice President the
title of Executive Vice President or Senior Vice President, and may assign to any Vice President or other officer any other title selected
by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.9   <U>Secretary
and Assistant Secretaries</U>. The Secretary shall perform such duties and shall have such powers as the Board or the Chief Executive
Officer may from time to time prescribe. In addition, the Secretary shall perform such duties and have such powers as are incident to
the office of the secretary, including without limitation the duty and power to give notices of all meetings of stockholders and special
meetings of the Board, to attend all meetings of stockholders and the Board and keep a record of the proceedings, to maintain a stock
ledger and prepare lists of stockholders and their addresses as required, to be custodian of corporate records and the corporate seal
and to affix and attest to the same on documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Assistant Secretary shall
perform such duties and possess such powers as the Board, the Chief Executive Officer or the Secretary may from time to time prescribe.
In the event of the absence, inability or refusal to act of the Secretary, the Assistant Secretary (or if there shall be more than one,
the Assistant Secretaries in the order determined by the Board) shall perform the duties and exercise the powers of the Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The chairman of any meeting
of the Board or of stockholders may designate a temporary secretary to keep a record of any meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.10  <U>Treasurer
and Assistant Treasurers</U>. The Treasurer shall perform such duties and shall have such powers as may from time to time be assigned
by the Board or the Chief Executive Officer. In addition, the Treasurer shall perform such duties and have such powers as are incident
to the office of treasurer, including without limitation the duty and power to keep and be responsible for all funds and securities of
the Corporation, to deposit funds of the Corporation in depositories selected in accordance with these Bylaws, to disburse such funds
as ordered by the Board, to make proper accounts of such funds, and to render as required by the Board statements of all such transactions
and of the financial condition of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Assistant Treasurers shall
perform such duties and possess such powers as the Board, the Chief Executive Officer or the Treasurer may from time to time prescribe.
In the event of the absence, inability or refusal to act of the Treasurer, the Assistant Treasurer (or if there shall be more than one,
the Assistant Treasurers in the order determined by the Board) shall perform the duties and exercise the powers of the Treasurer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.11  <U>Delegation
of Authority</U>. The Board may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding
any provision hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV<BR>
<FONT STYLE="text-transform: uppercase">CAPITAL STOCK</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1   <U>Stock
Certificates; Uncertificated Shares</U>. The shares of the Corporation shall be represented by certificates, <U>provided</U> that the
Board may provide by resolution or resolutions that some or all of any or all classes or series of the Corporation&rsquo;s stock shall
be uncertificated shares. Every holder of stock of the Corporation represented by certificates shall be entitled to have a certificate,
in such form as may be prescribed by law and by the Board, representing the number of shares held by such holder registered in certificate
form. Each such certificate shall be signed in a manner that complies with Section 158 of the DGCL and each of the Chief Executive Officer,
the President, a Vice President, the Secretary, an Assistant Secretary, the Treasurer or an Assistant Treasurer are duly authorized to
sign such certificates by, or in the name of, the Corporation, unless otherwise expressly provided in the resolution of the Board electing
such officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each certificate for shares
of stock which are subject to any restriction on transfer pursuant to the Certificate of Incorporation, these Bylaws, applicable securities
laws or any agreement among any number of stockholders or among such holders and the Corporation shall have conspicuously noted on the
face or back of the certificate either the full text of the restriction or a statement of the existence of such restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Corporation shall be
authorized to issue more than one class of stock or more than one series of any class, the powers, designations, preferences and relative
participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions
of such preferences and/or rights shall be set forth in full or summarized on the face or back of each certificate representing shares
of such class or series of stock, <U>provided</U> that in lieu of the foregoing requirements there may be set forth on the face or back
of each certificate representing shares of such class or series of stock a statement that the Corporation will furnish without charge
to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights
of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Within a reasonable time after
the issuance or transfer of uncertificated shares, the registered owner thereof shall be given a notice, in writing or by electronic transmission,
containing the information required to be set forth or stated on certificates pursuant to Sections 151, 156, 202(a) or 218(a) of the DGCL
or, with respect to Section 151 of DGCL, a statement that the Corporation will furnish without charge to each stockholder who so requests
the powers, designations, preferences and relative participating, optional or other special rights of each class of stock or series thereof
and the qualifications, limitations or restrictions of such preferences and/or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2   <U>Transfers</U>.
Shares of stock of the Corporation shall be transferable in the manner prescribed by law, the Certificate of Incorporation and in these
Bylaws. Transfers of shares of stock of the Corporation shall be made only on the books of the Corporation or by transfer agents designated
to transfer shares of stock of the Corporation. Subject to applicable law, shares of stock represented by certificates shall be transferred
only on the books of the Corporation by the surrender to the Corporation or its transfer agent of the certificate representing such shares
properly endorsed or accompanied by a written assignment or power of attorney properly executed, and with such proof of authority or the
authenticity of signature as the Corporation or its transfer agent may reasonably require. Except as may be otherwise required by law,
by the Certificate of Incorporation or by these Bylaws, the Corporation shall be entitled to treat the record holder of stock as shown
on its books as the owner of such stock for all purposes, including the payment of dividends and the right to vote with respect to such
stock, regardless of any transfer, pledge or other disposition of such stock until the shares have been transferred on the books of the
Corporation in accordance with the requirements of these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3   <U>Lost,
Stolen or Destroyed Certificates</U>. The Corporation may issue a new certificate or uncertificated shares in place of any previously
issued certificate alleged to have been lost, stolen or destroyed, upon such terms and conditions as the Corporation may prescribe, including
the presentation of reasonable evidence of such loss, theft or destruction and the giving of such indemnity and posting of such bond sufficient
to indemnify the Corporation against any claim that may be made against it on account of the alleged loss, theft or destruction of any
such certificate or the issuance of such new certificate or uncertificated shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4   <U>Record
Date</U>. In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment
thereof, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date
is adopted by the Board, and which record date shall, unless otherwise required by law, not be more than sixty (60) nor less than ten
(10) days before the date of such meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders
entitled to vote at such meeting unless the Board determines, at the time it fixes such record date, that a later date on or before the
date of the meeting shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining
stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding
the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting
is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment
of the meeting; <U>provided</U>, <U>however</U>, that the Board may fix a new record date for determination of stockholders entitled to
vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned
meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order that the Corporation
may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled
to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board
may fix a record date, which shall not be more than sixty (60) days prior to such action. If no such record date is fixed, the record
date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board adopts the resolution
relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">4.5   <U>Regulations</U>.
The issue and registration of shares of stock of the Corporation shall be governed by such other regulations as the Board may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE V<BR>
<FONT STYLE="text-transform: uppercase">GENERAL PROVISIONS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1   <U>Fiscal
Year</U>. Except as from time to time otherwise designated by the Board, the fiscal year of the Corporation shall begin on the first day
of January of each year and end on the last day of December in each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2   <U>Corporate
Seal</U>. The corporate seal shall be in such form as shall be approved by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3   <U>Waiver
of Notice</U>. Whenever notice is required to be given by law, by the Certificate of Incorporation or by these Bylaws, a written waiver
signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before, at or
after the time of the event for which notice is to be given, shall be deemed equivalent to notice required to be given to such person.
Neither the business nor the purpose of any meeting need be specified in any such waiver. Attendance of a person at a meeting shall constitute
a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of
the meeting, to the transaction of any business because the meeting is not lawfully called or convened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4   <U>Voting
of Securities</U>. Except as the Board may otherwise designate, the Chief Executive Officer, the President, the Chief Financial Officer
or the Treasurer may waive notice, vote, consent, or appoint any person or persons to waive notice, vote or consent, on behalf of the
Corporation, and act as, or appoint any person or persons to act as, proxy or attorney-in-fact for the Corporation (with or without power
of substitution and re-substitution), with respect to the securities of any other entity which may be held by this Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5   <U>Evidence
of Authority</U>. A certificate by the Secretary, or an Assistant Secretary, or a temporary Secretary, as to any action taken by the stockholders,
directors, a committee or any officer or representative of the Corporation shall as to all persons who rely on the certificate in good
faith be conclusive evidence of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6   <U>Certificate
of Incorporation</U>. All references in these Bylaws to the Certificate of Incorporation shall be deemed to refer to the Certificate of
Incorporation of the Corporation, as amended and/or restated and in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7   <U>Severability</U>.
Any determination that any provision of these Bylaws is for any reason inapplicable, illegal or ineffective shall not affect or invalidate
any other provision of these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8   <U>Pronouns</U>.
All pronouns used in these Bylaws shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of
the person or persons may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9   <U>Manner
of Notice.</U> Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders
given by the Corporation under any provision of the DGCL, the Certificate of Incorporation or these Bylaws may be given in writing directed
to the stockholder&rsquo;s mailing address (or by electronic transmission directed to the stockholder&rsquo;s electronic mail address,
as applicable) as it appears on the records of the Corporation. Notice shall be given (i) if mailed, when deposited in the United States
mail, (ii) if delivered by courier service, the earlier of when the notice is received or left at the stockholder&rsquo;s address, or
(iii) if given by electronic mail, when directed at to such stockholder&rsquo;s electronic mail address (unless the stockholder has notified
the Corporation in writing or by electronic transmission of an objection to receiving notice by electronic mail or such notice is prohibited
by the DGCL to be given by electronic transmission). A notice by electronic mail must include a prominent legend that the communication
is an important notice regarding the Corporation. A notice by electronic mail shall be deemed to include any files attached thereto and
any information hyperlinked to a website if such electronic mail includes the contact information of an officer or agent of the Corporation
who is available to assist with accessing such files or information. Any notice to stockholders under any provision of the DGCL, the Certificate
of Incorporation or these Bylaws provided by electronic transmission (other than any such notice given by electronic mail) may only be
given in a form consented to by such stockholder, and any such notice by electronic transmission shall be deemed to be given as provided
by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10  <U>Electronic
Transmission</U>. For purposes of these Bylaws, &ldquo;electronic transmission&rdquo; means any form of communication, not directly involving
the physical transmission of paper, including the use of, or participation in, one or more electronic networks or databases (including
one or more distributed electronic networks or databases), that creates a record that may be retained, retrieved, and reviewed by a recipient
thereof, and that may be directly reproduced in paper form by such a recipient through an automated process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE VI<BR>
<FONT STYLE="text-transform: uppercase">AMENDMENTS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These Bylaws may be altered,
amended or repealed, in whole or in part, or new Bylaws may be adopted by the Board or by the stockholders as expressly provided in the
Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE VII<BR>
<FONT STYLE="text-transform: uppercase">INDEMNIFICATION AND ADVANCEMENT</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1   <U>Power
to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Corporation</U>. Subject to Section 7.3, the
Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation)
by reason of the fact that such person is or was a director or officer of the Corporation, or, while a director or officer of the Corporation,
is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint
venture, trust, employee benefit plan or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted
in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe such person&rsquo;s conduct was unlawful. The termination
of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall
not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to
be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable
cause to believe that such person&rsquo;s conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2   <U>Power
to Indemnify in Actions, Suits or Proceedings by or in the Right of the Corporation</U>. Subject to Section 7.3, the Corporation shall
indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit
by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director or
officer of the Corporation, or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as
a director, officer, employee or agent of another Corporation, partnership, joint venture, trust, employee benefit plan or other enterprise
against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with the defense or settlement
of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the
best interests of the Corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such
person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery or the court
in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all
the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery
or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3   <U>Authorization
of Indemnification</U>. Any indemnification under this Article VII (unless ordered by a court) shall be made by the Corporation only as
authorized in the specific case upon a determination that indemnification of the director or officer is proper in the circumstances because
such person has met the applicable standard of conduct set forth in Section 7.1 or Section 7.2, as the case may be. Such determination
shall be made, with respect to a person who is a director or officer at the time of such determination, (i) by a majority vote of the
directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (ii) by a committee of such directors
designated by a majority vote of such directors, even though less than a quorum, or (iii) if there are no such directors, or if such directors
so direct, by independent legal counsel in a written opinion or (iv) by the stockholders. Such determination shall be made, with respect
to former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Corporation. To
the extent, however, that a present or former director or officer of the Corporation has been successful on the merits or otherwise in
defense of any action, suit or proceeding set forth in Section 7.1 or Section 7.2 or in defense of any claim, issue or matter therein,
such person shall be indemnified against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by such person in
connection therewith, without the necessity of authorization in the specific case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4   <U>Good
Faith Defined</U>. For purposes of any determination under Section 7.3, a person shall be deemed to have acted in good faith and in a
manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, or, with respect to any criminal
action or proceeding, to have had no reasonable cause to believe such person&rsquo;s conduct was unlawful, if such person&rsquo;s action
is based on good faith reliance on the records or books of account of the Corporation or another enterprise, or on information supplied
to such person by the officers of the Corporation or another enterprise in the course of their duties, or on the advice of legal counsel
for the Corporation or another enterprise or on information or records given or reports made to the Corporation or another enterprise
by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Corporation or another
enterprise. The term &ldquo;another enterprise&rdquo; as used in this Section 7.4 shall mean any other corporation or any partnership,
joint venture, trust, employee benefit plan or other enterprise of which such person is or was serving at the request of the Corporation
as a director, officer, employee or agent. The provisions of this Section 7.4 shall not be deemed to be exclusive or to limit in any way
the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section 7.1 or 7.2, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.5   <U>Right
of Claimant to Bring Suit</U>. Notwithstanding any contrary determination in the specific case under Section 7.3, and notwithstanding
the absence of any determination thereunder, if a claim under Sections 7.1 or 7.2 of the Article VII is not paid in full by the Corporation
within (i) ninety (90) days after a written claim for indemnification has been received by the Corporation following the final disposition
of the underlying action, suit or proceeding, or (ii) thirty (30) days after a written claim for an advancement of expenses has been received
by the Corporation, the claimant may at any time thereafter (but not before) bring suit against the Corporation in the Court of Chancery
in the State of Delaware to recover the unpaid amount of the claim, together with interest thereon, or to obtain advancement of expenses,
as applicable. It shall be a defense to any such action brought to enforce a right to indemnification (but not in an action brought to
enforce a right to an advancement of expenses) that the claimant has not met the standards of conduct which make it permissible under
the DGCL (or other applicable law) for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such
defense shall be on the Corporation. Neither a contrary determination in the specific case under Section 7.3 nor the absence of any determination
thereunder shall be a defense to such application or create a presumption that the claimant has not met any applicable standard of conduct.
If successful, in whole or in part, the claimant shall also be entitled to be paid the expense of prosecuting such claim, including reasonable
attorneys&rsquo; fees incurred in connection therewith, to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.6   <U>Expenses
Payable in Advance</U>. Expenses, including without limitation attorneys&rsquo; fees, incurred by a current or former director or officer
in defending any civil, criminal, administrative or investigative action, suit or proceeding shall be paid by the Corporation in advance
of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such current or former director
or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation
as authorized in this Article VII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.7   <U>Nonexclusivity
of Indemnification and Advancement of Expenses</U>. The rights to indemnification and advancement of expenses provided by or granted pursuant
to this Article VII shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses
may be entitled under the Certificate of Incorporation, any agreement, vote of stockholders or disinterested directors or otherwise, both
as to action in such person&rsquo;s official capacity and as to action in another capacity while holding such office, it being the policy
of the Corporation that, subject to Section 7.11, indemnification of the persons specified in Sections 7.1 and 7.2 shall be made to the
fullest extent permitted by law. The provisions of this Article VII shall not be deemed to preclude the indemnification of any person
who is not specified in Section 7.1 or 7.2 but whom the Corporation has the power or obligation to indemnify under the provisions of the
DGCL, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.8   <U>Insurance</U>.
The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the
Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise against any liability asserted against such person and incurred
by such person in any such capacity, or arising out of such person&rsquo;s status as such, whether or not the Corporation would have the
power or the obligation to indemnify such person against such liability under the provisions of this Article VII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.9   <U>Certain
Definitions</U>. For purposes of this Article VII, references to &ldquo;the Corporation&rdquo; shall include, in addition to the resulting
corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if
its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents so
that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request
of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise, shall stand in the same position under the provisions of this Article VII with respect to the resulting
or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued.
For purposes of this Article VII, references to &ldquo;fines&rdquo; shall include any excise taxes assessed on a person with respect of
any employee benefit plan; and references to &ldquo;serving at the request of the Corporation&rdquo; shall include any service as a director,
officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer, employee or agent
with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such
person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to
have acted in a manner &ldquo;not opposed to the best interests of the Corporation&rdquo; as referred to in this Article VII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.10  <U>Survival
of Indemnification and Advancement of Expenses</U>. The indemnification and advancement of expenses provided by, or granted pursuant to,
this Article VII shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director
or officer and shall inure to the benefit of the heirs, executors and administrators of such a person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.11  <U>Limitation
on Indemnification</U>. Notwithstanding anything contained in this Article VII to the contrary, except for proceedings to enforce rights
to indemnification (which shall be governed by Section 7.5), the Corporation shall not be obligated to indemnify any director, officer,
employee or agent in connection with an action, suit proceeding (or part thereof) initiated by such person unless such action, suit or
proceeding (or part thereof) was authorized by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.12  <U>Contract
Rights</U>. The obligations of the Corporation under this Article VII to indemnify, and advance expenses to, a person who is
or was a director or officer of the Corporation shall be considered a contract between the Corporation and such person, and no modification
or repeal of any provision of this Article VII shall affect, to the detriment of such person, such obligations of the Corporation in connection
with a claim based on any act or failure to act occurring before such modification or repeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE VIII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORUM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 41pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1   <U>Forum</U>.  Unless
the Corporation consents in writing to the selection of an alternative forum, (A) (i) any derivative action or proceeding brought on behalf
of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other
employee or stockholder of the Corporation to the Corporation or the Corporation&rsquo;s stockholders, (iii) any action asserting a claim
arising pursuant to any provision of the DGCL, the Certificate of Incorporation or these Bylaws or as to which the DGCL confers jurisdiction
on the Court of Chancery of the State of Delaware or (iv) any action asserting a claim governed by the internal affairs doctrine of the
law of the State of Delaware shall, to the fullest extent permitted by law, be exclusively brought in the Court of Chancery of the State
of Delaware or, if such court does not have subject matter jurisdiction thereof, the federal district court of the State of Delaware;
and (B) the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a
cause of action arising under the Securities Act of 1933, as amended. Notwithstanding the foregoing, this Article VIII shall not apply
to claims seeking to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended. To the fullest extent permitted
by law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the Corporation shall
be deemed to have notice of and consented to the provisions of this Article VIII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">14</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.3
<SEQUENCE>4
<FILENAME>ea190803ex3-3_pasithea.htm
<DESCRIPTION>CERTIFICATE OF TERMINATION OF CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PASITHEA THERAPEUTICS CORP., DATED DECEMBER 29, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF AMENDMENT TO THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED<BR>
CERTIFICATE OF INCORPORATION<BR>
OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PASITHEA THERAPEUTICS CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Section 103(d)
of the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;), Pasithea Therapeutics Corp., a corporation organized
and existing under the laws of the State of Delaware, does hereby certify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIRST: That a Certificate
of Amendment to the Amended and Restated Certificate of Incorporation was filed in the office of the Secretary of State of the State of
Delaware on December 28, 2023 by Pasithea Therapeutics Corp. (the &ldquo;Certificate of Amendment&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: That the Certificate
of Amendment provided that said Certificate of Amendment would be effective at 12:01 a.m. Eastern Time on January 2, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIRD: That the Certificate
of Amendment is hereby terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, Pasithea
Therapeutics Corporation has caused this Certificate of Termination to be signed by its duly authorized officer this 29th day of December,
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold">PASITHEA THERAPEUTICS CORP.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-style: italic"><FONT STYLE="font-style: normal; font-weight: normal">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-style: italic">/s/ Tiago Reis Marques</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 31%">Tiago Reis Marques</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>5
<FILENAME>ea190803ex3-4_pasithea.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PASITHEA THERAPEUTICS CORP., DATED DECEMBER 29, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.4</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE OF AMENDMENT TO THE<BR>
SECOND AMENDED AND RESTATED<BR>
CERTIFICATE OF INCORPORATION<BR>
OF<BR>
PASITHEA THERAPEUTICS CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pasithea Therapeutics Corp. (the &ldquo;<U>Company</U>&rdquo;),
a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FIRST: </B>That the certificate of incorporation
of the Corporation, as heretofore amended and restated (the &ldquo;<U>Current Charter</U>&rdquo;) is hereby amended as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article&nbsp;IV of the Current Charter, be and
hereby is further amended by replacing paragraph (A)&nbsp;of Article&nbsp;IV with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;(A)&nbsp;<U>Classes of Stock</U>. The total
number of shares of all classes of capital stock that the Company is authorized to issue is 105,000,000&nbsp;shares. The authorized capital
stock is divided into: (i) 100,000,000&nbsp;shares of common stock having a par value of $0.0001 per share (hereinafter, the &ldquo;<U>Common
Stock</U>&rdquo;) and (ii)&nbsp;5,000,000&nbsp;shares of preferred stock having a par value of $0.0001 per share (hereinafter, the &ldquo;<U>Preferred
Stock</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the effectiveness (&ldquo;<U>Effective Time</U>&rdquo;)
of the filing of this Certificate of Amendment, a one-for-twenty reverse stock split (the &ldquo;<U>Reverse Split</U>&rdquo;) of the Company&rsquo;s
Common Stock, par value $0.0001 per share, shall become effective, pursuant to which each twenty shares of Common Stock issued and outstanding
and held of record by each stockholder of the Company or issued and held by the Company in treasury immediately prior to the Effective
Time (&ldquo;<U>Old Common Stock</U>&rdquo;) shall automatically, and without any action by the Company or the holder thereof, be reclassified
and combined into one (1)&nbsp;validly issued, fully paid and non-assessable share of Common Stock (&ldquo;<U>New Common Stock</U>&rdquo;).
The Reverse Split shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Old Common
Stock and all references to such Old Common Stock in agreements, arrangements, documents and plans relating thereto or any option or right
to purchase or acquire shares of Old Common Stock shall be deemed to be references to the New Common Stock or options or rights to purchase
or acquire shares of New Common Stock, as the case may be, after giving effect to the Reverse Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional shares of Common Stock will be issued
as a result of or in connection with the Reverse Split. Stockholders of record who otherwise would be entitled to receive fractional shares,
will be entitled to receive a cash payment (without interest) in lieu of fractional shares, equal to such fraction multiplied by the average
of the closing sales prices of our Common Stock on the exchange the Company is currently trading during regular trading&nbsp;hours for
the five consecutive&nbsp;trading days immediately preceding the effective date of the Reverse Split (with such average closing sales
prices being adjusted to give effect to the Reverse Split).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each holder of record of a certificate or certificates
for one or more shares of the Old Common Stock shall be entitled to receive as soon as practicable, upon surrender of such certificate,
a certificate or certificates representing the largest whole number of shares of New Common Stock to which such holder shall be entitled
pursuant to the provisions of the immediately preceding paragraphs. Each stock certificate that, immediately prior to the Effective Time,
represented shares of Old Common Stock that were issued and outstanding immediately prior to the Effective Time shall, from and after
the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares
of New Common Stock after the Effective Time into which the shares formerly represented by such certificate have been reclassified as
well as the right to receive cash in lieu of fractional shares of New Common Stock after the Effective Time.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SECOND: </B>The amendments set forth in this
Certificate of Amendment were duly adopted by the Board of Directors of the Corporation and the stockholders of the Corporation in accordance
with Section&nbsp;242 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIRD: </B>This Certificate of Amendment&nbsp;shall
be effective as of 12:01 am&nbsp;Eastern Time on January 2, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF, </B>the Corporation has
caused this Certificate of Amendment to be signed by its Chief Executive Officer this 29th&nbsp;day of December, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PASITHEA THERAPEUTICS CORP.</B></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Tiago
Reis Marques</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tiago Reis Marques</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Executive Officer and Director</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ktta-20231229.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWa2I+aPtyJ1xWYkxuG97fUl6vywofwS6ayt7WSjWUR4I -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:KTTA="http://pasithea.com/20231229" elementFormDefault="qualified" targetNamespace="http://pasithea.com/20231229">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://pasithea.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231229_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="KTTA_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ktta-20231229_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pasithea.com/role/Cover" xlink:href="ktta-20231229.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pasithea.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTACommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTACommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ktta-20231229_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="KTTA_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KTTA_CommonStockParValue0.0001PerShareMember" xlink:to="KTTA_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KTTA_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:to="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Warrants to purchase shares of Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ktta-20231229_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pasithea.com/role/Cover" xlink:href="ktta-20231229.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://pasithea.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTACommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTACommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231229.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140385598300336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 29,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Pasithea Therapeutics Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001841330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-1591963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4400 Route 9 South<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 3100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami Beach<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">977-3380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KTTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember', window );">Warrants to purchase shares of Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase shares of Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KTTAW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>ea190803-8k_pasithea_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:KTTA="http://pasithea.com/20231229"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ktta-20231229.xsd" xlink:type="simple"/>
    <context id="AsOf2023-12-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2023-12-29">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2023-12-29">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-12-29">0001841330</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2023-12-29">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-12-29">2023-12-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-12-29">Pasithea Therapeutics Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-12-29">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-12-29">001-40804</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-12-29">85-1591963</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-12-29">4400 Route 9 South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-12-29">Suite 3100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-12-29">Miami Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-12-29">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-12-29">33139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-12-29">786</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-12-29">977-3380</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-12-29">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-12-29">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-12-29">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-12-29">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember">KTTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-12-292023-12-29_custom_CommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">Warrants to purchase shares of Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">KTTAW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-12-292023-12-29_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-12-29">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-12-29">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #TA2)8JL0B%C,!   B @  #P
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M2P$"% ,4    " #TA2)8FLV(^N\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #TA2)8F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( /2%(E@H=G=/[@0  %H5   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #TA2)8X/0ZB:H"   P#
M#0              @ $R#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /2%
M(EB7BKL<P    !,"   +              "  0<0  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( /2%(EBJQ"(6,P$  "("   /              "  ? 0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #TA2)8)!Z;HJT   #X 0  &@
M            @ %0$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #TA2)899!YDAD!  #/ P  $P              @ $U$P  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  !_%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea190803-8k_pasithea.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pasithea.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea190803-8k_pasithea.htm">ea190803-8k_pasithea.htm</File>
    <File>ktta-20231229.xsd</File>
    <File>ktta-20231229_def.xml</File>
    <File>ktta-20231229_lab.xml</File>
    <File>ktta-20231229_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea190803-8k_pasithea.htm": {
   "nsprefix": "KTTA",
   "nsuri": "http://pasithea.com/20231229",
   "dts": {
    "inline": {
     "local": [
      "ea190803-8k_pasithea.htm"
     ]
    },
    "schema": {
     "local": [
      "ktta-20231229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ktta-20231229_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ktta-20231229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ktta-20231229_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 28
   },
   "report": {
    "R1": {
     "role": "http://pasithea.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea190803-8k_pasithea.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea190803-8k_pasithea.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pasithea.com/20231229",
     "localname": "WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares of Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "KTTA_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pasithea.com/20231229",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-24-000296-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-000296-xbrl.zip
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M!M1UF&J3FFD-TC%'0E9 <EOUD0(TCL C$5@^T$2QB3V@*FJ)&F&PIXY-@"L
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M;A#SJ@5B-DXY&SQX;QG^R6LR/&7GX68O>/>O6>FK9J63T'3!28UQB"MX#KP
M [5#]6B"=<&"538F;P:L1+\T,ZJT;#)0+T=X#%&'5D6-3B8&]ET24AE(!D&
M3NJ-80YUJG6IJ+LE[&Y2R94+\%Z2PA=%U]2QIHYY! UIO9G<K2+[6M3'@&L3
ME"\9+S@I+H#8QSGRY#NON(97#0=N)4DX'&%7F_&[1LBWA9"W@(^F:TL)5M&
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ML+$(D3**'DO07]B3NAU&18;:C.092CO"(G8D*F+X8/32)+E&!3<"(6N%$/X
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M#@@SA4*0%M\"2 !Q*(1"C6A\4%3XG"68?UW'8BBS<6 \$ E).+!V\UD=IMV
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M0P3GA?[AG1K_7D%TV(MM-CNY+I#O4 L1AK*>N-*6-QDO%>-1[%KGI1.C4H'
M->H6=T,6>0<FDR-_0@V9 B=\9WG (L&<4D!"P$F2J+\%Q>/HN=>@W%7&Z4L7
MN //,B8'Q81=DU64DJ N@$@,04!?F ?*)[!B>J4)0Y4.EZ:,T0>%&TN4;:EI
M*E/OG!$!!0#S=^4:V!@)2C<998GOKX[,BX.M&#:+%0/'.<^15/3>,E_#_+['
M>DDV;9TV.1W[#F:]OLUGS^!?CK'=),^H\B/#Y<"=*]9?O1*[6\]_V<!E:#IV
MV3G4DQ(6S#$B_ILVZQ[C^EM@<GZ9Q(]K*/S/?@_S+J6F\FGD1[3^>Y@5S.%5
MV+@G:I2CSR7^M+_5._C?;SRBI[&/[N&[>OG3=V5\5R]_^J[F68?_^Z2%2T^
MBNX:0.]4_-GKGW8O+\6?[[L7W;.W.)C E_=C3.*7]"Z2KWLG&3N7%-G.E:ZA
MHQY,92'E3U7( D%*8RR0QK'[.A^+4%+AQK$:*C[7>W=[]_G?0<#W.X<G77'4
M/3FY/.\<]4[?_;:VO4;?SSO'Q_;[@T=WH\-\C+=N_U(*HV$217*:P;:TG]9H
M-^WW+]P.GHWD1$>S-W=U00?0#65D9PW;>\WNSO[QPUL$3GM[=MK_D@<M3?%Y
MV"/]8V<<1V=(V=/?UG;7GG!,>X+NS8 ]><%H'YUW+GO]]]T.CPX^773.NW^
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M"#Q._,V[0B*0N!BF''@Q&A!V#-Q]. 8VVV*!+&:>IZ.:SGE>K("G-B:0^+9
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MIMH6\6U-KM]ZSSU[^["+CG'S?<^<O5"45K]B[MK&L&BS-?!"UJG=(20 AN;
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M&8D)TT3VF7&V:\+!;57%*ZI.0.[&IBK;I0>I$VR*O)Z<O^N9$R?/U9J>W'X
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M-%J;DY@? 'TT0WJUL&I?W\-U7G8WPB=B#?:',)XF)XCVR:V^6$LII0.1AW>
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M#CJMT]4)P%R"_,#$C,,']GTU(R<H7B0+' Q4-TYU,_-I:_F+DK"0%M&4$"0
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MMB][2!8?-21+>%_8--JV:$LLES+4DNK'.;JS9*OM)D<0L!]X;RE3+GE;B?9
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M'<H.=GJ>ESJ")N-DFZ/00AM*R#DN/2*I2MN.+PV?)2*OYOV05+RE,GG,VS.
M XMKJ58@D!C%^'H-U3#0N;>++3,BRK2TDK)!^[.,@4_I Y4 F45NM>B9^!@M
M>;H0SEAW+70DO>THB!;;12-G&^<EF>!82*01E, $DR%O]D-'N8 V+ 35&1B
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M9&5F+GAM;-5=77/B.!9]WZK]#U[VF1#(9':3Z>P432=35'^$#4SW[KZDA"U
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M?<SVN"$32,&\%?3;4;_Z7;F?DN"_&(G: NR-6T1_'C-(OJ,,>!0*D8-6VO-
MUHVFOQ0TR+^CG/>:*:)V9F7;MQ"X\ZS-#JT:S;<5+,BSHT0W!I7>^F#*+-XK
MXSIOV0*^+8!!SATEN#&PD88O$!VS &\_XUT9Z0>F+6#=AABDW5%B&R.;"+)&
M8C<E?G7'<FC; N*MD$'F'66S,;09VHX#'019D'C=:[4 @$L+="A##LKA*)V-
M$8Z9S\6&9^YWCWBHK]K=B >E0T"I8PNDJ<8/"N0HYXUQ#H- 8"F3/R:N?IDL
M%O,6B &A!A^ .<I_(72#XR08M%*"0;D$CO)?"-W9<1*<M5*"LW()'&7!.70C
M_?%6S/@3\/0=,&X/_0>80?*=IL )MBB:6S$1_)'$VXBJ%#CP:(\,-N"@%D[3
MY+2=Q-.%.E=!;-D>[K. 0<Z=ILD)L F7"M'_D4W5[-1FWQ[^B[!!%1QES4F+
M,+=1H&57.9-&<UU$"M+K*#4V8\Y08 0WZZQ%L\D]! IRZRC/_<+-4YT59Z7W
MD ^M&LVQ%2S(LZMTU>SBDV#WL#_=:&;S*"%*7[Q1XDA*?PBB-!ZSOCQDR1TD
MX,F?U;315,.(0=H=I9Q33HFO&6++KSH.01"U<UZT:S3A %R0;4?9Y41@TP:P
MGN1'B^',5F!QNUA /35LWVCV*V"#*CA*,P_@C:4,L3A6BX)7FQ2Q@P=U<91R
M3K$?ZHYRUQ_,9V:K.] 3'5@UFG<K6)!G1VGF-SX3R+R99[I;SSF%M_!8#!O-
M-H07)-Q11IE#9:<Z9])HDHM(07H=993I17:]]5>(+3&\HL-FV6BR0< @YXXR
MS>>.;5FKKUZVJ:]>UNBK'66:*:AXH;Z^[F[GE"P1O".PQ*$5[$.X(2%L,;V%
M$/%^+?.^-[&.4-WH#W8)K*:-)A]&#-+N:BML&!"%@QC@#6&(^3J9VP<%W"&H
M\FJV&'7 @[HX?4[Z U/ZF?$G-L5(<H:#.+$H>UH!N#1:D6KDH!Q.GYQ^YS1D
M"HEHR:T K@VK:0OHMR$&:7?ZD#195KX?N>(7@9:Q;_=H@0@EP$$MG#X\'3.%
M!?(5><2?D$()WC(M[!XMT*($.*B%TX7'T84ZTO$L>?G:@9QA"Y@OX@4)=[K>
M>+I&E'X,I0Y EO8_.<,6$%[$"Q+N=$7Q]1J+I>X&_Q#\2:V2C;QEQ%L=6B
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M;U??N!_N+R+8(_\"4$L! A0#%     @ ](4B6&\C>NS (P  [  ! !@
M         ( !     &5A,3DP.# S+3AK7W!A<VET:&5A+FAT;5!+ 0(4 Q0
M   ( /2%(E@LZ3^]-!H  '*7   :              "  ?8C  !E83$Y,#@P
M,V5X,RTQ7W!A<VET:&5A+FAT;5!+ 0(4 Q0    ( /2%(EC[XS(ZRE(  )VJ
M 0 :              "  6(^  !E83$Y,#@P,V5X,RTR7W!A<VET:&5A+FAT
M;5!+ 0(4 Q0    ( /2%(E@;*XK%M00  $P6   :              "  621
M  !E83$Y,#@P,V5X,RTS7W!A<VET:&5A+FAT;5!+ 0(4 Q0    ( /2%(EBB
M90Y\?PD  -DD   :              "  5&6  !E83$Y,#@P,V5X,RTT7W!A
M<VET:&5A+FAT;5!+ 0(4 Q0    ( /2%(EC[:")ZRP,   $/   1
M      "  0B@  !K='1A+3(P,C,Q,C(Y+GAS9%!+ 0(4 Q0    ( /2%(EC1
M.K!0^0@  ,EH   5              "  0*D  !K='1A+3(P,C,Q,C(Y7V1E
M9BYX;6Q02P$"% ,4    " #TA2)8!D[5#NT+  "?D   %0
M@ $NK0  :W1T82TR,#(S,3(R.5]L86(N>&UL4$L! A0#%     @ ](4B6"!(
MOXM!"   8V,  !4              ( !3KD  &MT=&$M,C R,S$R,CE?<')E
:+GAM;%!+!08     "0 ) &X"  #"P0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
